About Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica
During the past decade, Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica"
#1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator and "Institut de Recherches Internationales Servier" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica
According to Clinical.Site data, the most researched conditions in "Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica" are
"Metastatic Colorectal Cancer" (1 trials) and "Refractory Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica" in a lesser frequency.
Clinical Trials Intervention Types at Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica
Most popular intervention types in "Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (1 trials), "Bevacizumab control" (1 trials), "Bevacizumab experimental" (1 trials), "Capecitabine" (1 trials) and "Trifluridine/Tipiracil" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica
The vast majority of trials in "Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica" are
2 trials for "All" genders.
Clinical Trials Status at Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica
Currently, there are NaN active trials in "Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".